| Revenue | DKK 436K | +1477% |
| EBITDA | DKK 30K | +10% |
| Net profit | DKK 21K | +7% |
| Total assets | DKK 87K | +86% |
| Equity | DKK -1K | +94% |
| Employees | 1 | — |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 163 | 351 | 269 | 537 | 230 | 287 | 472 | 3 | 28 | 436 |
| Staff expenses | -139 | -371 | -195 | -485 | -267 | -282 | -435 | -0 | -0 | -406 |
| EBITDA | 24 | -19 | 74 | 52 | -37 | 5 | 37 | 3 | 28 | 30 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 24 | -19 | 74 | 52 | -37 | 5 | 37 | 3 | 28 | 30 |
| Net financials | 0 | -1 | -1 | -1 | 2 | -1 | -2 | -0 | -2 | -1 |
| Profit before tax | 24 | -14 | 73 | 51 | -35 | 4 | 34 | 3 | 26 | 29 |
| Tax | 6 | 3 | 17 | 13 | -7 | 7 | 2 | 1 | 6 | 8 |
| Net profit | 18 | -17 | 56 | 38 | -28 | -3 | 32 | 2 | 20 | 21 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 131 | 112 | 149 | 59 | 15 | 0 | 26 | 20 | 47 | 87 |
| Equity | 68 | 50 | 107 | -45 | -73 | -77 | -45 | -42 | -23 | -1 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 63 | 62 | 42 | 104 | 87 | 77 | 71 | 62 | 70 | 89 |
| Total debt | 63 | 62 | 42 | 104 | 87 | 77 | 71 | 62 | 70 | 89 |
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2016 | |
Joakim Engel Holding IVS | Company | 100.0% | 100.0% | 2016 |
| Person | Role here | Other companies |
|---|